Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 28

Sort by

Sort Order Select

Journal Articles

Impact of Extramedullary Disease on the Outcomes after Allogeneic Hematopoietic Cell Transplantation in Children and Young Adults with Acute Myeloid Leukemia - a CIBMTR Analysis

Hemalatha Rangarajan, Deepak Chellapandian, Rasha Atshan, Kwang Wooahn, Akshay Sharma, Kirk R. Schultz, Parinda A. Mehta, Christine L. Phillips, Larisa Broglie, Prakash Satwani

Blood (2024) 144 (Supplement 1): 2412.

https://doi.org/10.1182/blood-2024-201848

Published: 2024

Journal Articles

Quercetin ameliorates XIAP deficiency–associated hyperinflammation

Samuel C. C. Chiang, Erika Owsley, Neelam Panchal, Vijaya Chaturvedi, Catherine E. Terrell, Michael B. Jordan, Parinda A. Mehta, Stella M. Davies, Nagako Akeno, Claire Booth, Rebecca A. Marsh

Blood (2022) 140 (7): 706–715.

https://doi.org/10.1182/blood.2021014335

Published: 2022

Includes: Supplemental data

Journal Articles

Reduced calf muscle pump function is a risk factor for venous thromboembolism: a population-based cohort study

Damon E. Houghton, Aneel Ashrani, David Liedl, Ramila A. Mehta, David O. Hodge, Thom Rooke, Paul Wennberg, Waldemar Wysokinski, Robert McBane

Blood (2021) 137 (23): 3284–3290.

https://doi.org/10.1182/blood.2020010231

Published: 2021

Includes: Supplemental data

Journal Articles

Association of clinical severity with FANCB variant type in Fanconi anemia

Moonjung Jung, Ramanagouda Ramanagoudr-Bhojappa, Sylvie van Twest, Rasim Ozgur Rosti, Vincent Murphy, Winnie Tan, Frank X. Donovan, Francis P. Lach, Danielle C. Kimble, Caroline S. Jiang, Roger Vaughan, Parinda A. Mehta, Filomena Pierri, Carlo Dufour, Arleen D. Auerbach, Andrew J. Deans, Agata Smogorzewska, Settara C. Chandrasekharappa

Blood (2020) 135 (18): 1588–1602.

https://doi.org/10.1182/blood.2019003249

Published: 2020

Includes: Supplemental data

Journal Articles

Gene Therapy for Sickle Cell Anemia Using a Modified Gamma Globin Lentivirus Vector and Reduced Intensity Conditioning Transplant Shows Promising Correction of the Disease Phenotype

Blood (2018) 132 (Supplement 1): 1021.

https://doi.org/10.1182/blood-2018-99-119591

Published: 2018

Journal Articles

Quercetin: A Novel Targeted Chemoprevention for Patients with Fanconi Anemia (FA)

Parinda A Mehta, MD, Tsuyoshi Fukuda, Junfang Zhao, Cancelas-Perez Jose, Sara Loveless, BSN, Kenneth Setchell, Alexander A. Vinks, Qishen Pang, Deborah Elder, Susan Rose, Kasiani C. Myers, MD, Adam S. Nelson, Stephanie Edwards, Adam Lane, Stella M Davies

Blood (2017) 130 (Supplement 1): 1178.

https://doi.org/10.1182/blood.V130.Suppl_1.1178.1178

Published: 2017

Journal Articles

Engraftment and in vivo proliferation advantage of gene-corrected mobilized CD34 + cells from Fanconi anemia patients

Paula Río, Susana Navarro, Guillermo Guenechea, Rebeca Sánchez-Domínguez, Maria Luisa Lamana, Rosa Yañez, Jose A. Casado, Parinda A. Mehta, Maria Roser Pujol, Jordi Surrallés, Sabine Charrier, Anne Galy, José C. Segovia, Cristina Díaz de Heredia, Julián Sevilla, Juan A. Bueren

Blood (2017) 130 (13): 1535–1542.

https://doi.org/10.1182/blood-2017-03-774174

Published: 2017

Includes: Supplemental data

Journal Articles

Radiation-free, alternative-donor HCT for Fanconi anemia patients: results from a prospective multi-institutional study

Parinda A. Mehta, Stella M. Davies, Thomas Leemhuis, Kasiani Myers, Nancy A. Kernan, Susan E. Prockop, Andromachi Scaradavou, Richard J. O’Reilly, David A. Williams, Leslie Lehmann, Eva Guinan, David Margolis, K. Scott Baker, Adam Lane, Farid Boulad

Blood (2017) 129 (16): 2308–2315.

https://doi.org/10.1182/blood-2016-09-743112

Published: 2017

Journal Articles

Transplant Associated Thrombotic Microangiopathy in Individuals with Fanconi Anemia

Kasiani C. Myers, MD, Sonata Jodele, MD, Adam S. Nelson, MBBS, Erica Goodridge, Parinda A Mehta, MD, Robin Mueller, Christopher E. Dandoy, MD, Adam Lane, PhD, Javier A. El-Bietar, MD, Stella M Davies, MBBS, PhD

Blood (2016) 128 (22): 2217.

https://doi.org/10.1182/blood.V128.22.2217.2217

Published: 2016

Journal Articles

Precision Dosing of Alemtuzumab: Population Pharmacokinetic Modeling in Pediatric Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Non-Malignant Diseases

Tsuyoshi Fukuda, PhD, Chie Emoto, PhD, Rebecca A Marsh, MD, Lisa Neumeier, BS, Alexander A. Vinks, PharmD, PhD, Parinda A Mehta, MD

Blood (2016) 128 (22): 2203.

https://doi.org/10.1182/blood.V128.22.2203.2203

Published: 2016

Journal Articles

HCT Outcome in Patients with Fanconi Anemia Transplanted at Adult Age

Blood (2016) 128 (22): 4691.

https://doi.org/10.1182/blood.V128.22.4691.4691

Published: 2016

Journal Articles

Alemtuzumab levels impact acute GVHD, mixed chimerism, and lymphocyte recovery following alemtuzumab, fludarabine, and melphalan RIC HCT

Rebecca A. Marsh, Adam Lane, Parinda A. Mehta, Lisa Neumeier, Sonata Jodele, Stella M. Davies, Alexandra H. Filipovich

Blood (2016) 127 (4): 503–512.

https://doi.org/10.1182/blood-2015-07-659672

Published: 2016

Journal Articles

Inducible Loss of the Fanconi Anemia Pathway in iPSC Causes Rapid Cell Cycle Arrest and Apoptosis through ATM/ATR and p53 Signaling

Timothy M Chlon, PhD, Elizabeth E Hoskins, Sonya Ruiz-Torres, Christopher N Mayhew, PhD, Kathryn A Wikenheiser-Brokamp, MD PhD, Stella M. Davies, MBBS, PhD, Parinda A. Mehta, Kasiani C. Myers, MD, James M Wells, PhD, Susanne I Wells, PhD

Blood (2014) 124 (21): 3528.

https://doi.org/10.1182/blood.V124.21.3528.3528

Published: 2014

Journal Articles

Transplantation for children with acute myeloid leukemia: a comparison of outcomes with reduced intensity and myeloablative regimens

Blood (2014) 123 (10): 1615–1620.

https://doi.org/10.1182/blood-2013-10-535716

Published: 2014

Journal Articles

Deletion Of Fanca Or Fancd2 Dysregulates Treg Activity and Exacerbates Gvhd In Mice

Wei Du, MD, PhD, Ozlem Erden, MS, Andrew Wilson, MS, Jared Sipple, Jonathan Schick, Parinda A. Mehta, Stella M. Davies, MBBS, PhD, Kris Steinbrecher, PhD, Qishen Pang, Ph.D

Blood (2013) 122 (21): 3239.

https://doi.org/10.1182/blood.V122.21.3239.3239

Published: 2013

Journal Articles

Chemotherapy-Only Preparative Regimen for T-Cell Depleted Hematopoietic Stem Cell Transplantation of Patients with Fanconi Anemia From Alternative Donors

Farid Boulad, MD, Stella M. Davies, MBBS, PhD, David A. Williams, MD, David A Margolis, MD, Elizabeth G Klein, Leslie E. Lehmann, MD, Christine Duncan, MD, MMSc, Eva C. Guinan, MD, Parinda A. Mehta

Blood (2012) 120 (21): 3471.

https://doi.org/10.1182/blood.V120.21.3471.3471

Published: 2012

Journal Articles

Prenatal Origin of Monosomy 7 in Very Young Children.

Parinda A. Mehta, M.D., Mark Wunderlich, MS, Teresa Smolarek, PhD, Stella M. Davies, MBBS, PhD, Sarah Zimmerman, PhD, Alexandra H. Filipovich, MD, Emmett H. Broxson, Jr., MD, Jose A. Cancelas, M.D. PhD., James C. Mulloy, PhD

Blood (2012) 120 (21): 2557.

https://doi.org/10.1182/blood.V120.21.2557.2557

Published: 2012

Journal Articles

Increased Oxidative Stress and Genomic Instability in Peripheral Blood and Bone Marrow of Individuals with Fanconi Anemia,

Kasiani C. Myers, MD, Gretchen A Radloff, Melissa Scholz, Lisa Campbell, Jennifer E Hauser, Parinda A Mehta, MD, Robin Mueller, Lisa Vormohr, Richard E. Harris, MD, Qishen Pang, PhD, Stella M. Davies, MBBS, PhD

Blood (2011) 118 (21): 3425.

https://doi.org/10.1182/blood.V118.21.3425.3425

Published: 2011

Journal Articles

Two-Year Safety and Tolerability of Velaglucerase Alfa in Patients with Type 1 Gaucher Disease, Including Patients Switched From Imiglucerase: Phase III Trial HGT-GCB-039 and Extension,

A Mehta, H Ben Turkia, DE Gonzalez, M Kabra, EA Lukina, P Giraldo, I Kisinovsky, A Bavdekar, M-F Ben Dridi, N Gupta, PS Kishnani, EK Sureshkumar, N Barton, N Wang, E Crombez, K Bhirangi, A Zimran

Blood (2011) 118 (21): 3214.

https://doi.org/10.1182/blood.V118.21.3214.3214

Published: 2011

Journal Articles

Reduced-intensity conditioning significantly improves survival of patients with hemophagocytic lymphohistiocytosis undergoing allogeneic hematopoietic cell transplantation

Rebecca A. Marsh, Gretchen Vaughn, Mi-Ok Kim, Dandan Li, Sonata Jodele, Sarita Joshi, Parinda A. Mehta, Stella M. Davies, Michael B. Jordan, Jack J. Bleesing, Alexandra H. Filipovich

Blood (2010) 116 (26): 5824–5831.

https://doi.org/10.1182/blood-2010-04-282392

Published: 2010

Includes: Supplemental data

NARROW

Impact of Extramedullary Disease on the Outcomes after Allogeneic Hematopoietic Cell Transplantation in Children and Young Adults with Acute Myeloid Leukemia - a CIBMTR Analysis

Quercetin ameliorates XIAP deficiency–associated hyperinflammation

Reduced calf muscle pump function is a risk factor for venous thromboembolism: a population-based cohort study

Association of clinical severity with FANCB variant type in Fanconi anemia

Gene Therapy for Sickle Cell Anemia Using a Modified Gamma Globin Lentivirus Vector and Reduced Intensity Conditioning Transplant Shows Promising Correction of the Disease Phenotype

Quercetin: A Novel Targeted Chemoprevention for Patients with Fanconi Anemia (FA)

Engraftment and in vivo proliferation advantage of gene-corrected mobilized CD34 + cells from Fanconi anemia patients

Radiation-free, alternative-donor HCT for Fanconi anemia patients: results from a prospective multi-institutional study

Transplant Associated Thrombotic Microangiopathy in Individuals with Fanconi Anemia

Precision Dosing of Alemtuzumab: Population Pharmacokinetic Modeling in Pediatric Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Non-Malignant Diseases

HCT Outcome in Patients with Fanconi Anemia Transplanted at Adult Age

Alemtuzumab levels impact acute GVHD, mixed chimerism, and lymphocyte recovery following alemtuzumab, fludarabine, and melphalan RIC HCT

Inducible Loss of the Fanconi Anemia Pathway in iPSC Causes Rapid Cell Cycle Arrest and Apoptosis through ATM/ATR and p53 Signaling

Transplantation for children with acute myeloid leukemia: a comparison of outcomes with reduced intensity and myeloablative regimens

Deletion Of Fanca Or Fancd2 Dysregulates Treg Activity and Exacerbates Gvhd In Mice

Chemotherapy-Only Preparative Regimen for T-Cell Depleted Hematopoietic Stem Cell Transplantation of Patients with Fanconi Anemia From Alternative Donors

Prenatal Origin of Monosomy 7 in Very Young Children.

Increased Oxidative Stress and Genomic Instability in Peripheral Blood and Bone Marrow of Individuals with Fanconi Anemia,

Two-Year Safety and Tolerability of Velaglucerase Alfa in Patients with Type 1 Gaucher Disease, Including Patients Switched From Imiglucerase: Phase III Trial HGT-GCB-039 and Extension,

Reduced-intensity conditioning significantly improves survival of patients with hemophagocytic lymphohistiocytosis undergoing allogeneic hematopoietic cell transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only